About Sino Biological
Sino Biological is a company based in Beijing (China) founded in 2007. Sino Biological has raised $29.41 million across 1 funding round from investors including Qiming Venture Partners. Sino Biological has completed 1 acquisition, including SignalChem. Sino Biological operates in a competitive market with competitors including Abcam, GenScript, Stem Cell Technologies, Miltenyi Biotec and Devyser, among others.
- Headquarter Beijing, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$29.41 M (USD)
in 1 rounds
-
Latest Funding Round
$29.41 M (USD), Series A
Jul 06, 2017
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Sino Biological
Unlock access to complete
Funding Insights of Sino Biological
Sino Biological has successfully raised a total of $29.41M through 1 strategic funding round. The most recent funding activity was a Series A round of $29.41 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sino Biological
Sino Biological has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Qiming Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are directed toward multiple sectors.
|
Locked | Locked | Locked |
Investor details for Sino Biological
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sino Biological
Sino Biological has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include SignalChem.
Investment portfolio details for Sino Biological
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Develops products for Cell signaling research
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for Sino Biological
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sino Biological
Detailed financials for Sino Biological
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sino Biological Comparisons
Peer comparison for Sino Biological
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sino Biological
Sino Biological operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, GenScript, Stem Cell Technologies, Miltenyi Biotec and Devyser, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
|
| Locked | Locked | Locked |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Detailed competitors of Sino Biological
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sino Biological
Complete news archive for Sino Biological
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sino Biological
Sino Biological was founded in 2007 and raised its 1st funding round 10 years after it was founded.
Sino Biological is headquartered in Beijing, China.
Sino Biological is a funded company, having raised a total of $29.41M across 1 funding round to date.
Sino Biological was established in 2007 in Beijing, China, within the biotechnology sector. Recombinant proteins, antibodies, and antibody-based kits are supplied for examining cellular functions and human diseases. Custom services in antibody development, protein production, and purification are also extended to support research operations. The companys domain, sinobiological.com, facilitates access to these resources globally.
Sino Biological's top competitors include Abcam, Meridian Bioscience and GenScript.
Sino Biological has made 1 acquisition, including SignalChem.
Sino Biological has 1 investor. Key investors include Qiming Venture Partners.